While an NF-κB expression decrease after ATL treatment was described in other cells, an observed decrease in NF-κB expression after 12-h exposure of dHepaRG cells to GER is in contrast to the lack of observed effect of GER on NF-κB expression in breast cancer cells [16]. This evidence concerns the gene NFKB1 and breast cancer.